CN105968197B - A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody - Google Patents
A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody Download PDFInfo
- Publication number
- CN105968197B CN105968197B CN201610318423.7A CN201610318423A CN105968197B CN 105968197 B CN105968197 B CN 105968197B CN 201610318423 A CN201610318423 A CN 201610318423A CN 105968197 B CN105968197 B CN 105968197B
- Authority
- CN
- China
- Prior art keywords
- protein
- antibody
- sample
- detection
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1253—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56933—Mycoplasma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to the immune chromatography reagent kits of anti-3 type Ureaplasma urealyticum MB protein antibodies and application the antibody test Ureaplasma urealyticum, anti- 3 type Ureaplasma urealyticum MB protein antibodies are the antibody for identifying linear epitope composed by 3 type Ureaplasma urealyticum MB protein 10 5-118 amino acids, and 3 type Ureaplasma urealyticum MB albumen are AAC41437.1 in GenBank sequence number;The amino acid sequence of 3 type Ureaplasma urealyticums MB protein 10 5-118 is KLPREPKPNEQLTI.3 type Ureaplasma urealyticum MB protein antibodies of rabbit-anti provided by the present invention have the characteristics that specificity is good, with high purity, potency is high, preparation cost is cheap.
Description
Technical field
The invention belongs to field of biomedicine technology, it is related to the anti-3 type Ureaplasma urealyticum MB protein antibodies of one kind and application should
The immune chromatography reagent kit of antibody test Ureaplasma urealyticum.
Background technique
Ureaplasma urealyticum (M.urealyticum) is to obtain unique one kind in Ureaplasma because growth needs urea
Name.There are two biota, 14 serotypes to be normally present in the asymptomatic crowd of health, thus it is speculated that may be only for Ureaplasma urealyticum
It is certain subgroups or Asian Development Bank with pathogenic.By dividing group the study found that in mankind's uropoiesis to different crowd urogenital tract
It is first group that the major part of infection is lived away from home and caused to genital tract, most commonly seen with 3 types.After ureaplasma urealyticum infection, patient is most
Non-evident sympton also easily causes doctor to fail to pinpoint a disease in diagnosis therefore, it is difficult to be perceived by patient.Ureaplasma urealyticum can invade urethra, uterine neck and preceding
The big gland in front yard, causes urethritis, cervicitis and bartholinitis;When uplink infects, endometritis, pelvic inflammatory disease, defeated ovum can be caused
Guan Yan, especially salpingitis are common.Female sex organ pathology caused by ureaplasma urealyticum infection sexually revises, and is infertile
Major reason.Data at home and abroad prompt, ureaplasma urealyticum positive rate is up in the cervical mucus of Infertile Couples, sperm
50% or more, it can be seen that, ureaplasma urealyticum infection and infertility have correlativity.Ureaplasma urealyticum infection causes not
Good reason is miscarriage, and someone checks that the positive rate of Ureaplasma urealyticum is up to 40% or more from the tissue of miscarriage.
The detection method of Ureaplasma urealyticum mainly has 3 classes at present: first is that isolated culture, is to confirm infection " gold mark
It is quasi- ", but since the growth cycle of Ureaplasma urealyticum is extremely slow, cultivation cycle is long, and leading to the method clinically not can be carried out fastly
Speed diagnosis;Second is that serological method, that is, use enzyme-linked immunization, colloidal gold immunization, micro-Immunofluorescence assay and indirect hemagglutination
Test etc. detects ureaplasma urealyticum antibodies level in examinee's serum, can prompt the presence of ureaplasma urealyticum infection indirectly.So
And serological test can only provide a kind of retrospective diagnosis, and sometimes for paired sera.In addition, antibody occur when
Machine is not easy to grasp, and there are the differences of Ureaplasma urealyticum specific antibody again between children and adolescents and adult, also, solves urea branch
Glycolipid antigen on somatoblast film and other microorganisms and body tissue are there are non-specific cross-reaction, therefore existing serology
The detection quality of method is subject to certain restrictions;Third is that using the presence of Protocols in Molecular Biology detection Ureaplasma urealyticum DNA, wherein
The most commonly used is polymerase chain reaction (PCR), and this method is quick, sensitive, special, are the important hands of current research Mp infection
Section, but since PCR is more demanding to experimental facilities and operation, and easily there is false positive, it can't be as common in China
Methods for clinical diagnosis.Therefore, it is very necessary to establish Ureaplasma urealyticum specific antigen diagnostic method.At present, it has been disclosed that report
The method for detecting Ureaplasma urealyticum antigen is mainly double crush syndrome method, indirect immunofluorescence etc., but these methods are not
Detection by bed can be carried out, needs to detect to specific occasion using specific instrument (such as microplate reader, luminoscope), not only not
The enough convenient and efficient and time is longer, and clinical application is more inconvenient.
Therefore, the fast diagnosis method for establishing Ureaplasma urealyticum specific antigen is very necessary.Due to most of pathogenic
Ureaplasma urealyticum is three type of serum, simultaneously because it is well-conserved in its outer membrane protein MB sequence, therefore obtain high special
Property anti-3 type Ureaplasma urealyticum MB protein antibodies be exactly a highly important job.Currently, about anti-3 type Ureaplasma urealyticums
MB protein antibodies report at most to be corresponding monoclonal antibody and polyclonal antibody.Monoclonal antibody the biggest advantage is to
It is specific high, but preparation method is cumbersome, high production cost limits its application.Polyclonal antibody then has specific low, effect
The defects such as valence is low.Therefore, the inexpensive anti-3 type Ureaplasma urealyticum MB protein antibodies for preparing high specific, high-titer, to realize
Quick detection to 3 type Ureaplasma urealyticums, just seems particularly significant.
Summary of the invention
For these technical problems present in background technique, the purpose of the present invention is to provide 3 type solution urea branch of identification is former
The immunochromatography reagent of the antibody and application of linear epitope composed by body MB protein 10 5-118 the amino acids antibody
Box.
Anti- 3 type Ureaplasma urealyticum MB protein antibodies, it is characterised in that: described that 3 type Ureaplasma urealyticum MB protein antibodies is resisted to be
Identify the antibody of linear epitope composed by 3 type Ureaplasma urealyticum MB protein 10 5-118 amino acids, the 3 type solution urea
Mycoplasma MB albumen is AAC41437.1 in GenBank sequence number;The 14 of 3 type Ureaplasma urealyticum MB protein 10 5-118
A amino acid sequence is KLPREPKPNEQLTI;By the sequence of MB protein 10 5-118 14 amino acid of 3 type Ureaplasma urealyticum
It is named as MB3Linearar;The 3 type MB protein antibodies of anti-Ureaplasma urealyticum are AbMB3Linearar.
One kind being formed by immune chromatography reagent kit based on anti-3 type Ureaplasma urealyticum MB protein antibodies as previously described,
Be characterized in that: the kit is immune chromatography reagent kit based on quantum dot-labeled technology or based on colloidal gold-labeled method
Immune chromatography reagent kit.
Preferably, when kit provided by the present invention is the immune chromatography reagent kit based on quantum dot-labeled technology,
The preparation method of the kit is:
1) quantum dot-labeled antibody A bMB3Linearar:
0.4nmol carboxyl water-soluble quantum dot and 800nmol carbodiimide EDC are sequentially added into microcentrifugal tube, with
MES buffer constant volume is 1ml, and mixed solution after 37 DEG C of reaction 5min, adds the antibody of 0.34mg being prepared
AbMB3Linearar is protected from light 2h, and single-ended amino-polyethyleneglycols PEG2000-NH2 to final concentration of 1% (m/v) is added, envelope
Unreacted activated carboxyl site is closed, continues to be protected from light 1h;Sample after reaction is centrifuged (molecular cut off with super filter tube
100k), 6500g is centrifuged 5min, until volume 200ul, sample after ultrafiltration is transferred in common EP pipe, centrifugation is obtained except reuniting
Upper clear supernate and lower part are precipitated, and are centrifuged 3min under the conditions of 10000g;Upper clear supernate is added on splitter Superdex-200
Purifying, flows into cylinder naturally to upper clear supernate, is then rinsed with PBS, and the position of sample is observed with ultraviolet light cylinder, to
Sample starts to collect since when lower part is flowed out, stops collecting after collecting 1ml;By the super filter tube (retention point of sample after purification
Son amount 100k) to be transferred in common EP pipe centrifugation after 6500g centrifugal concentrating to 200ul except reuniting, to common EP pipe carry out from
The condition of the heart is 10000g, 3min;Liquid is saved with phosphate after acquisition supernatant and dilutes 200 times, 4 DEG C save backup;So far it is made
Solution containing quantum dot labelled antibody AbMB3Linearar;
Each component content is respectively in the MES buffer: 10.66g/L MES and 0.74g/L EDTA, the MES
The pH 7.4 of buffer;
The phosphate save liquid preparation method be weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate,
0.2g sodium chloride, 1g bovine serum albumin(BSA) BSA and 0.1gNaN3, it is dissolved in the deionized water of 90ml, with 1mol/L NaOH
100ml is settled to deionized water after tune pH to 7.3;
2) bonding pad is prepared
Polyester fiber film is immersed in the obtained solution containing quantum dot labelled antibody AbMB3Linearar of step 1)
1h takes out, and is cut into after rear specification is 4cm × 0.6cm/ item after 25 DEG C of drying, and 4 DEG C are sealed spare, so far obtained bonding pad;
3) sample pad is prepared
It takes glass fibre element film one to open, glass fibre element film is impregnated at least 3h in sample pad treatment fluid, then be placed in life
In object safety cabinet after 37 DEG C of aeration-dryings, specification is cut into after 4cm × 2.5cm/ item, to obtain sample pad, 25 DEG C of sealings are protected
It deposits;
The preparation method of the sample pad treatment fluid be weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate,
0.2g sodium chloride, 2g bovine serum albumin(BSA) BSA, 1ml Tween-20,2g sucrose and 0.5g polyvinylpyrrolidone PVP-10, it is molten
Solution is settled to 100ml with deionized water in the deionized water of 90ml, with after 1mol/L NaOH tune pH to 7.3;
4) detection layers are prepared
4.1) preparation of anti-MB protein polyclone antibody:
4.1.1) the clone of related gene
To 3 type Ureaplasma urealyticum MB albumen, (the accession number in its NCBI Protein Data Bank is
AAC41437.1 bioinformatic analysis) is carried out, epitope peptide the most abundant in the extracellular conserved domain of its N-terminal is obtained
Section finds the corresponding DNA encoding sequence of the peptide fragment, while introducing restriction enzyme site NdeI, 3 ' ends at 5 ' ends of this DNA encoding sequence
(Jin Siruisheng is transferred in complete sequence synthesis to chemical synthesis complete genome sequence respectively after introducing termination signal TAA and restriction enzyme site XhoI
Object Science and Technology Ltd. completes, and when delivery, artificial synthesized genetic fragment was respectively connected on carrier pUC57), it is denoted as MB3,
Gene complete sequence is as shown in sequence table.The protein sequence of MB3 gene coding is natural 3 type Ureaplasma urealyticum memebrane protein MB
The 30-150aa of (accession number:AAC41437.1).By the carrier containing this section of artificial synthesized DNA fragmentation
Target fragment is separately recovered in pUC57 according to a conventional method after carrying out double digestion with NdeI and XhoI respectively, spare.NdeI is used simultaneously
And XhoI carries out double digestion to carrier pET-28a (+), and according to a conventional method respectively connects the MB3 gene obtained after double digestion
Enter in pET-28a (+) carrier, and convert Escherichia coli TOP10, constructs pET-MB3 expression vector.It is demonstrate,proved through digestion and sequencing
Real expression vector establishment is errorless.Carrier expression recombination MB3-His fusion protein.
4.1.2 the expression and purification of MB3-His fusion protein) is recombinated
Plasmid will be extracted after identifying correct positive colony bacterium culture, routinely technology is transferred to competence E.coli BL21
(DE3) in, bacterium solution is coated on the LB plate containing 50 μ g/mL kanamycins after the completion of conversion, according to a conventional method screening expression
Bacterial strain.The single bacterium colony with exogenous protein expression ability and inoculation that picking pET-MB3 is converted enter in 100mL LB culture medium,
In 37 DEG C of overnight incubations.After taking out bacterium solution, 100mL is inoculated in by 1:100 and is contained in the LB culture medium of 50 μ g/mL kanamycins,
In 37 DEG C of cultures to OD600When=0.6,1mol/L IPTG to final concentration of 1mmol/L is added, bacterium culture, induction are shaken in 37 DEG C
Expressing fusion protein.10min collection thallus is centrifuged under 8000r/min after inducing 4h.By this thallus 20mL phosphate-buffered
Liquid washs 3 times and with 10mL sample-loading buffer (20mM Na3PO4, 0.5M NaCl;30mM imidazoles, pH7.4) be resuspended after surpassed
Sound is broken, operating condition are as follows: 50HZ, 200W, ultrasonic 3S, interval 5S work 100 times.After the completion of ultrasound, 12000g centrifugation
15min carries out electrophoresis detection after collecting precipitating and supernatant respectively.It was found that recombinant protein MB3-His is present in bacterium in a manner of soluble
In body.
The purification step for recombinating MB3-His fusion protein is as follows:
His Trap affinity is used after the ultrasonication supernatant of above-mentioned acquisition is filtered with 0.45 μm of filter membrane
Columns (GE healthcare Products), is purified with same method to specifications.The specific method is as follows:
1) it is filled distilled water with 5mL syringe, unscrews the plug of column, connected column with syringe with the connector of offer,
Column is washed with 1mL/min flow velocity.
2) it is balanced with 10mL sample-loading buffer, 1mL/min flow velocity.
3) by fusion protein loading, 1mL/min flow velocity.
4) 10mL sample-loading buffer is used, column is washed with 1mL/min flow velocity.
5) 10mL elution buffer (20mM Na is used3PO4, 0.5M NaCl, 300mM imidazoles, pH7.4), it is flowed with 1mL/min
Speed elution, is in charge of collection, and every pipe 1ml, 12%SDS-PAGE detection merge the sample containing destination protein in elution fraction.Through
After bradford kit carries out determination of protein concentration, adjustment concentration is 0.2mg/mL.
4.1.3) the preparation of anti-MB protein polyclone antibody
With the recombination MB3-His fusion protein of above-mentioned purifying, according to 200 μ g, (200 μ g recombinate the total of MB3-His fusion protein
Volume is 1mL) with 1mL Freund's complete adjuvant mix emulsification after be immunized Male New Zealand White Rabbit (by Hubei Province's disease prevention control
Center processed provides), in dorsal sc multi-point injection, it is spaced after 7d and is immunized again once, with the recombination of above-mentioned purifying after 14d
P1-His fusion protein is incomplete with 1mL Freund according to 200 μ g (it is 1mL that 200 μ g, which recombinate the total volume of MB3-His fusion protein)
Adjuvant carries out booster immunization after mixing emulsification, and booster immunization is primary again in same way as described above again after booster immunization 7d.It is taken after 7d
Haemanalysis antibody titer.If dissatisfied, one may be repeated to booster immunization twice, until antibody titer satisfaction (uses indirect ELISA
Method measures antibody titer and is greater than 1 × 105).The Culling heart blood if satisfied separates serum, with Protein G affinity column (GE
Healthcare Products), in strict accordance with operational manual purified polyclonal antibodies IgG, with triumphant base Braford protein content
Detection kit measurement antibody concentration is simultaneously adjusted to 1mg/mL with phosphate buffer, and -20 DEG C of preservations are spare, and anti-MB is so far made
Protein polyclone antibody.
4.2) detection layers are prepared
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone being prepared according to the above method is resisted
It is respectively 2.0mg/mL and 1.0mg/mL that body and goat anti-rabbit igg, which are adjusted with phosphate buffer to final concentration,;It is anti-by what is diluted
MB protein polyclone antibody is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter, shape
At detection line;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, the amount of 1.0 μ l/cm of setting is sprayed on cellulose nitrate
Nature controlling line is used as on plain film, nature controlling line and detection line spacing are 0.7cm;37 DEG C of the nitrocellulose filter dry 2h that will have been sprayed, cut
It is cut into the specification of 4cm × 4cm, 4 DEG C of hermetically dryings save;So far detection layers are made;
The preparation method of the phosphate buffer is: weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate with
And 0.2g sodium chloride, it is dissolved in the deionized water of 90ml, is settled to after 1mol/L NaOH tune pH to 7.3 with deionized water
100ml;
5) assembling detection card
5.1) bottom plate is cut into 4cm × 7.3cm size, it is spare;
5.2) absorbent filter is cut into 4cm × 3cm size, it is spare as water absorption pad;
5.3) adhered protection film on bottom plate that step 5.1) is prepared is taken off, is by detection layers described in step 4)
Nitrocellulose filter with nature controlling line and detection line pastes on bottom plate, and smoothes out film surface;
5.4) the ready water absorption pad of step 5.2) is assembled on bottom plate, makes the left side of water absorption pad and the right end of detection layers
There is the overlapping of 0.2cm, the right hand edge of water absorption pad is then aligned with the right hand edge of bottom plate and glues and smooth out;Again by knot described in step 2)
It closes pad to be overlapped at the left edge of detection layers by 0.3cm, 0.3cm is sticked on bottom plate;
5.5) sample pad described in step 3) is then overlapped at the left edge of bonding pad by one side 0.3cm, another side with
The left edge of bottom plate is aligned, and is sticked on bottom plate and is smoothed out;Assembled detection plate is cut into the detection of 4.0mm wide under cutting machine
Card, 4 DEG C of hermetically dryings are kept in dark place.
Preferably, when kit provided by the present invention is the immune chromatography reagent kit based on colloidal gold-labeled method,
The preparation method of the kit is:
1) colloidal gold labeled monoclonal antibody AbMB3Linearar:
1.1) 30nm colloidal gold solution is prepared:
99ml ultrapure water is added, by 1ml 1% (m/v) HAuCl in the 250ml triangular flask for taking a silication good4Solution is added
It is mixed in 250ml triangular flask and with ultrapure water, oil bath heating is simultaneously stirred to boiling;2ml is rapidly joined into 250ml triangular flask
1% (m/v) trisodium citrate aqueous solution, solution continue the 10min that boils, are changed into the solution in 250ml triangular flask by blue
Stop heating when red, then the solution cooled to room temperature in 250ml triangular flask is added super into 250ml triangular flask
Pure water polishing is to 100ml;
1.2) colloidal gold labeled monoclonal antibody AbMB3Linear:
1.2.1 colloidal gold solution prepared by 10ml step 1.1) is added in the 50ml triangular flask for) taking a silication good, to
240ul 0.2mol/L K is added in colloidal gold liquid2CO3Adjust pH to 8.5;
1.2.2) under magnetic stirrer, antibody A bMB3Linear is added in colloidal gold solution, until antibody is dense eventually
Degree is 10ug/ml, is added dropwise when antibody is added, and continues to stir 45min~60min after adding;
1.2.3) reaction completes that 5% (m/v) bovine serum albumin(BSA) BSA to final concentration of 1% (m/v) is added, and stirring 15~
30 minutes, 4 DEG C saved backup;
1.2.4 50ml centrifuge tube is packed into after) taking out the antibody A bMB3Linear marked, 2500g, 4 DEG C are centrifuged 5 points
Clock obtains lower sediment and supernatant liquor, discards lower sediment, and supernatant liquor is transferred to another 50ml centrifuge tube, 12000g,
4 DEG C are centrifuged 30 minutes, obtain lower sediment and supernatant liquor, discard supernatant liquor, and lower sediment 10ml colloidal gold is buffered
Precipitating is resuspended in liquid, then 12000g again, and 4 DEG C are centrifuged 30 minutes, obtains lower sediment and supernatant liquor again, most by lower sediment
It is resuspended afterwards with 3ml colloidal gold buffer, 4 DEG C save backup, and obtain the solution containing colloidal gold labeled monoclonal antibody AbMB3Linear;
Each component content is respectively in the colloidal gold buffer: 10mM Tris, 1%m/vBSA, 1%v/v Tween-
20,5%m/v sucrose and 3 ‰ m/v polyvinylpyrrolidone PVP-10, the pH of the colloidal gold buffer are 10.5;
2) bonding pad is prepared
Polyester fiber film is immersed in the obtained solution containing colloidal gold labeled monoclonal antibody AbMB3Linear of step 1)
1h takes out, and is cut into after rear specification is 4cm × 0.6cm/ item after 25 DEG C of drying, and 4 DEG C are sealed spare, so far obtained bonding pad;
3) sample pad is prepared
It takes glass fibre element film one to open, glass fibre element film is impregnated at least 2h in sample pad treatment fluid, then be placed in life
In object safety cabinet after 37 DEG C of aeration-dryings, specification is cut into after 4cm × 1.5cm/ item, to obtain sample pad, 25 DEG C of sealings are protected
It deposits;
The preparation method of the sample pad treatment fluid be weigh 0.242g Tris, 1g bovine serum albumin(BSA) BSA, 1ml are spat
Temperature -20,5g sucrose and 0.3g polyvinylpyrrolidone PVP-10, are dissolved in the deionized water of 90ml, with 1mol/L NaOH
100ml is settled to deionized water after tune pH to 11;
4) detection layers are prepared
4.1) preparation of anti-MB protein polyclone antibody:
4.1.1) the clone of related gene
To 3 type Ureaplasma urealyticum MB albumen, (the accession number in its NCBI Protein Data Bank is
AAC41437.1 bioinformatic analysis) is carried out, epitope peptide the most abundant in the extracellular conserved domain of its N-terminal is obtained
Section finds the corresponding DNA encoding sequence of the peptide fragment, while introducing restriction enzyme site NdeI, 3 ' ends at 5 ' ends of this DNA encoding sequence
(Jin Siruisheng is transferred in complete sequence synthesis to chemical synthesis complete genome sequence respectively after introducing termination signal TAA and restriction enzyme site XhoI
Object Science and Technology Ltd. completes, and when delivery, artificial synthesized genetic fragment was respectively connected on carrier pUC57), it is denoted as MB3,
Gene complete sequence is as shown in sequence table.The protein sequence of MB3 gene coding is natural 3 type Ureaplasma urealyticum memebrane protein MB
The 30-150aa of (accession number:AAC41437.1).Its protein complete sequence is as shown in sequence table.The section will be contained
Mesh is separately recovered after carrying out double digestion with NdeI and XhoI respectively in the carrier pUC57 of artificial synthesized DNA fragmentation according to a conventional method
Segment, it is spare.Double digestion is carried out to carrier pET-28a (+) using NdeI and XhoI simultaneously, and according to a conventional method respectively will be through
The MB3 gene obtained after double digestion is connected into pET-28a (+) carrier, and converts Escherichia coli TOP10, building pET-MB3 expression
Carrier.Confirm that expression vector establishment is errorless through digestion and sequencing.Carrier expression recombination MB3-His fusion protein.
4.1.2 the expression and purification of MB3-His fusion protein) is recombinated
Plasmid will be extracted after identifying correct positive colony bacterium culture, routinely technology is transferred to competence E.coli BL21
(DE3) in, bacterium solution is coated on the LB plate containing 50 μ g/mL kanamycins after the completion of conversion, according to a conventional method screening expression
Bacterial strain.The single bacterium colony with exogenous protein expression ability and inoculation that picking pET-MB3 is converted enter in 100mL LB culture medium,
In 37 DEG C of overnight incubations.After taking out bacterium solution, 100mL is inoculated in by 1:100 and is contained in the LB culture medium of 50 μ g/mL kanamycins,
In 37 DEG C of cultures to OD600When=0.6,1mol/L IPTG to final concentration of 1mmol/L is added, bacterium culture, induction are shaken in 37 DEG C
Expressing fusion protein.10min collection thallus is centrifuged under 8000r/min after inducing 4h.By this thallus 20mL phosphate-buffered
Liquid washs 3 times and with 10mL sample-loading buffer (20mM Na3PO4, 0.5M NaCl;30mM imidazoles, pH7.4) be resuspended after surpassed
Sound is broken, operating condition are as follows: 50HZ, 200W, ultrasonic 3S, interval 5S work 100 times.After the completion of ultrasound, 12000g centrifugation
15min carries out electrophoresis detection after collecting precipitating and supernatant respectively.It was found that recombinant protein MB3-His is present in bacterium in a manner of soluble
In body.
The purification step for recombinating MB3-His fusion protein is as follows:
His Trap affinity is used after the ultrasonication supernatant of above-mentioned acquisition is filtered with 0.45 μm of filter membrane
Columns (GE healthcare Products), is purified with same method to specifications.The specific method is as follows:
1) it is filled distilled water with 5mL syringe, unscrews the plug of column, connected column with syringe with the connector of offer,
Column is washed with 1mL/min flow velocity.
2) it is balanced with 10mL sample-loading buffer, 1mL/min flow velocity.
3) by fusion protein loading, 1mL/min flow velocity.
4) 10mL sample-loading buffer is used, column is washed with 1mL/min flow velocity.
5) 10mL elution buffer (20mM Na is used3PO4, 0.5M NaCl, 300mM imidazoles, pH7.4), it is flowed with 1mL/min
Speed elution, is in charge of collection, and every pipe 1ml, 12%SDS-PAGE detection merge the sample containing destination protein in elution fraction.Through
After bradford kit carries out determination of protein concentration, adjustment concentration is 0.2mg/mL.
4.1.3) the preparation of anti-MB protein polyclone antibody
With the recombination MB3-His fusion protein of above-mentioned purifying, according to 200 μ g, (200 μ g recombinate the total of MB3-His fusion protein
Volume is 1mL) with 1mL Freund's complete adjuvant mix emulsification after be immunized Male New Zealand White Rabbit (by Hubei Province's disease prevention control
Center processed provides), in dorsal sc multi-point injection, it is spaced after 7d and is immunized again once, with the recombination of above-mentioned purifying after 14d
P1-His fusion protein is incomplete with 1mL Freund according to 200 μ g (it is 1mL that 200 μ g, which recombinate the total volume of MB3-His fusion protein)
Adjuvant carries out booster immunization after mixing emulsification, and booster immunization is primary again in same way as described above again after booster immunization 7d.It is taken after 7d
Haemanalysis antibody titer.If dissatisfied, one may be repeated to booster immunization twice, until antibody titer satisfaction (uses indirect ELISA
Method measures antibody titer and is greater than 1 × 105).The Culling heart blood if satisfied separates serum, with Protein G affinity column (GE
Healthcare Products), in strict accordance with operational manual purified polyclonal antibodies IgG, with triumphant base Braford protein content
Detection kit measurement antibody concentration is simultaneously adjusted to 1mg/mL with phosphate buffer, and -20 DEG C of preservations are spare, and anti-MB is so far made
Protein polyclone antibody.
4.2) detection layers are prepared
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone being prepared according to the above method is resisted
It is respectively 2.0mg/mL and 1.0mg/mL that body and goat anti-rabbit igg, which are adjusted with phosphate buffer to final concentration,;It is anti-by what is diluted
MB protein polyclone antibody is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter, shape
At detection line;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, the amount of 1.0 μ l/cm of setting is sprayed on cellulose nitrate
Nature controlling line is used as on plain film, nature controlling line and detection line spacing are 0.7cm;37 DEG C of the nitrocellulose filter dry 2h that will have been sprayed, cut
It is cut into the specification of 4cm × 4cm, 4 DEG C of hermetically dryings save;So far detection layers are made;
The preparation method of the phosphate buffer is: weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate with
And 0.2g sodium chloride, it is dissolved in the deionized water of 90ml, is settled to after 1mol/L NaOH tune pH to 7.3 with deionized water
100ml;
5) assembling detection card
5.1) bottom plate is cut into 4cm × 6cm size, it is spare;
5.2) absorbent filter is cut into 4cm × 2.5cm size, it is spare as water absorption pad;
5.3) adhered protection film on bottom plate that step 5.1) is prepared is taken off, is by detection layers described in step 4)
Nitrocellulose filter with nature controlling line and detection line pastes on bottom plate, and smoothes out film surface;
5.4) the ready water absorption pad of step 5.2) is assembled on bottom plate, makes the left side of water absorption pad and the right end of detection layers
There is the overlapping of 0.2cm, the right hand edge of water absorption pad is then aligned with the right hand edge of bottom plate and glues and smooth out;Again by knot described in step 2)
It closes pad to be overlapped at the left edge of detection layers by 0.2cm, 0.4cm is sticked on bottom plate;
5.5) sample pad described in step 3) is then overlapped at the left edge of bonding pad by one side 0.2cm, another side with
The left edge of bottom plate is aligned, and is sticked on bottom plate and is smoothed out;Assembled detection plate is cut into the detection of 4.0mm wide under cutting machine
Card, 4 DEG C of hermetically dryings are kept in dark place.
The invention has the advantages that
The present invention provides anti-3 type Ureaplasma urealyticum MB protein antibodies, the anti-3 type Ureaplasma urealyticum MB protein antibodies identifications
Linear epitope composed by 14 amino acid of 3 type Ureaplasma urealyticums MB protein 10 5-118,3 type Ureaplasma urealyticum MB
Albumen is AAC41437.1 in GenBank sequence number;The ammonia of 14 amino acid of 3 type Ureaplasma urealyticums MB protein 10 5-118
Base acid sequence is KLPREPKPNEQLTI;By the sequence designations of MB protein 10 5-118 14 amino acid of 3 type Ureaplasma urealyticum
For MB3Linear;Anti- 3 type Ureaplasma urealyticum MB protein antibodies are AbMB3Linear.Based on Ureaplasma urealyticum single linear antigen
Above-mentioned 3 type Ureaplasma urealyticum MB protein antibodies of rabbit-anti prepared by epitope are good, with high purity with specificity, potency is high, is prepared into
This cheap feature can be used for producing the highly sensitive detection Ureaplasma urealyticum of the various principles based on antigen-antibody reaction
Detection kit.Meanwhile resisting 3 type Ureaplasma urealyticum MB protein antibodies that two different immunochromatographies have also been prepared based on this
Kit.Two different immune chromatography reagent kits can quickly, accurately detect the Ureaplasma urealyticum in biological sample, include
Antibody of the present invention;Two kinds of immune chromatography reagent kits are used equally for the auxiliary diagnosis of ureaplasma urealyticum infection, have higher
Sensitivity and specificity, combined it is simple, quickly, the advantages such as stable and manufacturing cost is low, be suitable for clinical samples
Inspection be also suitable for epidemiological survey and since large batch of quick inspection can be carried out.Therefore, of the present invention
3 type Ureaplasma urealyticum MB protein antibodies of rabbit-anti, two kinds of immune chromatography reagent kits all have broad application prospect and practical valence
Value.
Specific embodiment
The present invention is further understood in order to facilitate those skilled in the art, it is detailed that preferred embodiment is cited below particularly
Illustrate the present invention.
" m/v " in present specification in concentration unit, when m unit is g, v unit is mL, belongs to the normal of this field
Know.
The source for a variety of materials that the present invention is used or used and the preparation of related reagent
1, sample pad treatment fluid: weighing 0.242g Tris, 1g bovine serum albumin(BSA) (BSA), 1ml Tween-20,5g sucrose,
0.3g polyvinylpyrrolidone (PVP-10), is dissolved in the deionized water of 90ml, with spending after 1mol/L NaOH tune pH to 11
Ionized water is settled to 100ml.
2, phosphate saves liquid: weighing 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate, 0.2g sodium chloride, 1g ox
Seralbumin BSA and 0.1gNaN3, it is dissolved in the deionized water of 90ml, with being spent after 1mol/L NaOH tune pH to 7.3
Ionized water is settled to 100ml;
3, phosphate buffer (PBS): weighing 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate, 0.2g sodium chloride,
It is dissolved in the deionized water of 90ml, is settled to 100ml with deionized water with after 1mol/L NaOH tune pH to 7.3.
4,0.0121g trishydroxymethylaminomethane, 0.17g sodium chloride, the dissolution of 0.025g lysozyme sample treatment liquid: are weighed
In 90ml deionized water, 100ml is settled to deionized water with after hydrochloric acid tune pH to 8.0.
5, it antibody A bMB3Linear: for present invention self-control, is diluted, is shaken up with PBS, make antibody concentration 3mg/ in solution
ml。
6, it anti-MB protein polyclone antibody: for present invention self-control, is diluted, is shaken up with PBS, make antibody concentration in solution
3mg/ml。
7, it goat anti-rabbit igg: for Wuhan Boster Biological Technology Co., Ltd.'s product, is diluted, is shaken up with PBS, made in solution
Anti-TNF-α bulk concentration is 1mg/ml.
8, quantum dot: quantum dot used is water-soluble CdSe/ZnS quantum of carboxylated amphipathic polymer modification in the present invention
Point, launch wavelength 565nm, from Wuhan Jia Yuan technology of quantum dots development corporation, Ltd., name of product is that carboxyl is water-soluble for purchase
Property quantum dot -565.
9, glass fibre element film: with a thickness of 0.4mm, water absorption 42mg/cm2, glass fiber diameter is 0.6-3 μm, tool
There is good hydrophily, buys in Shanghai Jinbiao Bio-Tech Co., Ltd. (model BT40).
10, polyester fiber film: with a thickness of 0.48mm, absorption speed 18s/4cm, there is fabulous hydrophily, for tying
The preparation of pad is closed, is bought in Shanghai Jinbiao Bio-Tech Co., Ltd. (model DL42).
11, nitrocellulose filter: model Millipore Corp SHF135 has liner plate, and purchase is in Millipore public affairs
Department.
12, absorbent filter: with a thickness of 0.95mm, absorption speed 60s/4cm, water absorption 700mg/cm2, have good
Water imbibition, as production water absorption pad material.It buys in Shanghai Jinbiao Bio-Tech Co., Ltd. (model CH37K).
13, bottom plate: for high whiteness PVC material, surface is coated with single layer high polymer pressure sensitive adhesive SM31-40, buys in Shanghai
Jin Biao Biotechnology Co., Ltd.
14, it Ureaplasma urealyticum: is purchased from American type culture collection (ATCC), number ATCC27815.
15, the microbiological specimens used in the present invention are purchased from American type culture collection (ATCC).
Technical solution provided by the present invention is described in detail below with reference to embodiment:
The preparation of 1 rabbit-anti of embodiment, 3 type Ureaplasma urealyticum MB albumen single-epitope antibody
3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti the preparation method is as follows:
1) after structure biology analysis and Related Experimental Study, 3 type Ureaplasma urealyticum MB albumen (GenBank sequences are selected
Row number AAC41437.1) 105-118 14 amino acid as preparation 3 type Ureaplasma urealyticum MB protein antibodies of rabbit-anti it is linear
Epitope, this section of amino acid sequence are KLPREPKPNEQLTI, are MB3Linear by this sequence designations;
2) automatic with polypeptide after the C-terminal of amino acid sequence MB3Linear described in step 1) being added a cysteine
Synthesizer synthesis polypeptide simultaneously purifies, polypeptide and carrier protein KLH after purification, forms MB3Linear-KLH compound protein;
3) compound protein synthesized by step 2) is emulsified, in rabbit subcutaneous abdomen multi-point injection after emulsification, successively injects three
It is secondary, every minor tick 7-10 days;
4) after third time injection 10-12 days, collection isolated contains 3 type Ureaplasma urealyticum MB albumen list epitope of rabbit-anti
The serum of antibody, ELISA detect the potency of 3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti in serum, the antibody
Potency is in 1:60000 or more;
5) step 2) is synthesized and the polypeptide purified and the Sepharose 4B of cyanogen bromide-activated is coupled, it is affine to form polypeptide
Chromatographic column;
6) serum containing 3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti that step 4) obtains is added to step
5) in the affinity column prepared, and after 4 DEG C are incubated overnight, antibody elution obtains 3 type Ureaplasma urealyticum MB albumen list of rabbit-anti
Epitope antibodies;Identify that the antibody of this purifying 97% or more, is named as AbMB3Linear by its purity through SDS-PAGE.
Step 2) -6 in the present embodiment) it is all existing mature technology, Duo Jia biotechnology company can provide sequencing
Technological service.In the present embodiment in above-mentioned steps related experiment link specific implementation, entrust Nanjing Jin Sirui biology section
Skill Co., Ltd completes.
" antibody " of the present invention should be construed to cover any specificity of the binding structural domain with required specificity
Binding factor.Thus, this term covers the function of antibody fragment homologous therewith, derivative, humanized antibody and antibody
It can coordinate and homologue.The example of antibody is that immunoglobulin hypotype (such as IgG, IgE, IgM, IgD and IgA) and its hypotype are sub-
Class;It is also possible to segment such as Fab, scFv, Fv, dAb, Fd and double-chain antibody comprising antigen-binding domains.
The preparation of the anti-MB protein polyclone antibody of embodiment 2:
1) clone of related gene
To 3 type Ureaplasma urealyticum MB albumen, (the accession number in its NCBI Protein Data Bank is
AAC41437.1 bioinformatic analysis) is carried out, epitope peptide the most abundant in the extracellular conserved domain of its N-terminal is obtained
Section finds the corresponding DNA encoding sequence of the peptide fragment, while introducing restriction enzyme site NdeI, 3 ' ends at 5 ' ends of this DNA encoding sequence
(Jin Siruisheng is transferred in complete sequence synthesis to chemical synthesis complete genome sequence respectively after introducing termination signal TAA and restriction enzyme site XhoI
Object Science and Technology Ltd. completes, and when delivery, artificial synthesized genetic fragment was respectively connected on carrier pUC57), it is denoted as MB3,
Gene complete sequence is as shown in sequence table.The protein sequence of MB3 gene coding is natural 3 type Ureaplasma urealyticum memebrane protein MB
The 30-150aa of (accession number:AAC41437.1).Its protein complete sequence is as shown in sequence table.The section will be contained
Mesh is separately recovered after carrying out double digestion with NdeI and XhoI respectively in the carrier pUC57 of artificial synthesized DNA fragmentation according to a conventional method
Segment, it is spare.Double digestion is carried out to carrier pET-28a (+) using NdeI and XhoI simultaneously, and according to a conventional method respectively will be through
The MB3 gene obtained after double digestion is connected into pET-28a (+) carrier, and converts Escherichia coli TOP10, building pET-MB3 expression
Carrier.Confirm that expression vector establishment is errorless through digestion and sequencing.Carrier expression recombination MB3-His fusion protein.
2) expression and purification of MB3-His fusion protein is recombinated
Plasmid will be extracted after identifying correct positive colony bacterium culture, routinely technology is transferred to competence E.coli BL21
(DE3) in, bacterium solution is coated on the LB plate containing 50 μ g/mL kanamycins after the completion of conversion, according to a conventional method screening expression
Bacterial strain.The single bacterium colony with exogenous protein expression ability and inoculation that picking pET-MB3 is converted enter in 100mL LB culture medium,
In 37 DEG C of overnight incubations.After taking out bacterium solution, 100mL is inoculated in by 1:100 and is contained in the LB culture medium of 50 μ g/mL kanamycins,
In 37 DEG C of cultures to OD600When=0.6,1mol/L IPTG to final concentration of 1mmol/L is added, bacterium culture, induction are shaken in 37 DEG C
Expressing fusion protein.10min collection thallus is centrifuged under 8000r/min after inducing 4h.By this thallus 20mL phosphate-buffered
Liquid washs 3 times and with 10mL sample-loading buffer (20mM Na3PO4, 0.5M NaCl;30mM imidazoles, pH7.4) be resuspended after surpassed
Sound is broken, operating condition are as follows: 50HZ, 200W, ultrasonic 3S, interval 5S work 100 times.After the completion of ultrasound, 12000g centrifugation
15min carries out electrophoresis detection after collecting precipitating and supernatant respectively.It was found that recombinant protein MB3-His is present in bacterium in a manner of soluble
In body.
The purification step for recombinating MB3-His fusion protein is as follows:
His Trap affinity is used after the ultrasonication supernatant of above-mentioned acquisition is filtered with 0.45 μm of filter membrane
Columns (GE healthcare Products), is purified with same method to specifications.The specific method is as follows:
A) it is filled distilled water with 5mL syringe, unscrews the plug of column, connected column with syringe with the connector of offer,
Column is washed with 1mL/min flow velocity.
B) it is balanced with 10mL sample-loading buffer, 1mL/min flow velocity.
C) by fusion protein loading, 1mL/min flow velocity.
D) 10mL sample-loading buffer is used, column is washed with 1mL/min flow velocity.
E) 10mL elution buffer (20mM Na is used3PO4, 0.5M NaCl, 300mM imidazoles, pH7.4), it is flowed with 1mL/min
Speed elution, is in charge of collection, and every pipe 1ml, 12%SDS-PAGE detection merge the sample containing destination protein in elution fraction.Through
After bradford kit carries out determination of protein concentration, adjustment concentration is 0.2mg/mL.
3) preparation of anti-MB protein polyclone antibody
With the recombination MB3-His fusion protein of above-mentioned purifying, according to 200 μ g, (200 μ g recombinate the total of MB3-His fusion protein
Volume is 1mL) with 1mL Freund's complete adjuvant mix emulsification after be immunized Male New Zealand White Rabbit (by Hubei Province's disease prevention control
Center processed provides), in dorsal sc multi-point injection, it is spaced after 7d and is immunized again once, with the recombination of above-mentioned purifying after 14d
P1-His fusion protein is incomplete with 1mL Freund according to 200 μ g (it is 1mL that 200 μ g, which recombinate the total volume of MB3-His fusion protein)
Adjuvant carries out booster immunization after mixing emulsification, and booster immunization is primary again in same way as described above again after booster immunization 7d.It is taken after 7d
Haemanalysis antibody titer.If dissatisfied, one may be repeated to booster immunization twice, until antibody titer satisfaction (uses indirect ELISA
Method measures antibody titer and is greater than 1 × 105).The Culling heart blood if satisfied separates serum, with Protein G affinity column (GE
Healthcare Products), in strict accordance with operational manual purified polyclonal antibodies IgG, with triumphant base Braford protein content
Detection kit measurement antibody concentration is simultaneously adjusted to 1mg/mL with phosphate buffer, and -20 DEG C of preservations are spare, and anti-MB is so far made
Protein polyclone antibody.
The preparation and application of immune chromatography reagent kit of the embodiment 3 based on quantum dot-labeled technology
1. quantum dot-labeled antibody A bMB3Linear
0.4nmol carboxyl water-soluble quantum dot and 800nmol carbodiimide (EDC) are sequentially added into microcentrifugal tube,
With MES buffer (10.66g/L MES, 0.74g/L EDTA pH 7.4) constant volume for 1ml, ceaselessly mixed solution, 37 DEG C anti-
After answering 5min, antibody A bMB3Linear prepared by the embodiment 1 of 0.34mg is added, 2h is protected from light, single-ended amino is added
Polyethylene glycol (PEG2000-NH2) closes unreacted activated carboxyl site, continues to be protected from light to final concentration of 1% (m/v)
1h.Sample after reaction is centrifuged (molecular cut off 100k) with super filter tube, and 6500g is centrifuged 5min, until volume 200ul, by ultrafiltration
Sample is transferred in common EP pipe afterwards, and centrifugation is except reunion (10000g, 3min).Upper clear supernate is added to splitter (Superdex-
200) purify on, flowed into cylinder naturally to it, then with PBS rinse (liquid flows down naturally), with ultraviolet light cylinder with
When observe sample position, when sample start since lower part flow out when collect, collect 1ml after stop collect.It will after purification
Sample is transferred to centrifugation in common EP pipe with super filter tube (molecular cut off 100k) after 6500g centrifugal concentrating to 200ul
(10000g, 3min) is except reunion.Liquid is saved with phosphate after acquisition supernatant and dilutes 200 times, 4 DEG C save backup.So far it is made and contains
There is the solution of quantum dot-labeled antibody A bMB3Linear.
2. the preparation of bonding pad
Polyester fiber film is immersed into 1h in the obtained solution containing quantum dot labelled antibody AbMB3Linear of step 1,
It takes out, is cut into after 25 DEG C of drying after rear specification is 4cm × 0.6cm/ item, 4 DEG C are sealed spare, so far obtained bonding pad.
3. the preparation of sample pad
It takes glass fibre element film one to open, it is impregnated at least 3h in sample pad treatment fluid, then be placed in Biohazard Safety Equipment
After 37 DEG C of aeration-dryings, specification is cut into obtain sample pad, 25 DEG C are sealed after 4cm × 2.5cm/ item.
4. the preparation of detection layers
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone antibody that embodiment 2 is prepared
Being adjusted with phosphate buffer to final concentration with goat anti-rabbit igg is respectively 2.0mg/mL and 1.0mg/mL;The rabbit-anti that will have been diluted
Recombination P1-His fusion protein polyclonal antibody IgG is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitre
On acid cellulose film, detection line is formed;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, 1.0 μ l/cm are set
Amount be sprayed on nitrocellulose filter as nature controlling line, nature controlling line and detection line spacing are 0.7cm;The nitrocellulose that will have been sprayed
37 DEG C of film dry 2h, are cut into the specification of 4cm × 4cm, and 4 DEG C of hermetically dryings save;So far detection layers are made.
5. detecting the assembling of card
Bottom plate is cut into 4cm × 7.3cm size, it is spare.
Absorbent filter is cut into 4cm × 3cm size, it is spare as water absorption pad.
Assembly working first takes the adhered protection film on bottom plate off in operating in Biohazard Safety Equipment, will be described in step 4
Detection layers have nature controlling line and the nitrocellulose filter of detection line pastes on bottom plate, and carefully smooth out film surface.Secondly, by thing
The water absorption pad first cut out is assembled on bottom plate, and having its left side and detection layers right end, 0.2cm's is overlapping, right hand edge then with bottom
The right hand edge alignment of plate is glued and is carefully smoothed out.Bonding pad described in step 2 is overlapped in the left edge of detection layers by 0.3cm again
Place, 0.3cm are sticked on bottom plate 7.Sample pad described in step 3 is finally then overlapped in by one side 0.3cm to the left edge of bonding pad
Place, another side is aligned with the left edge of bottom plate, sticks on bottom plate and carefully smoothes out.Assembled detection plate is cut out under cutting machine
At the detection card of 4.0mm wide, 4 DEG C of hermetically dryings are kept in dark place.
6. the composition of the immune chromatography reagent kit based on quantum dot-labeled technology
Immune chromatography reagent kit based on quantum dot-labeled technology detection card as described in step 5 and sample treatment liquid institute group
At.
7. the application method of the immune chromatography reagent kit based on quantum dot-labeled technology
The 500 μ l of urine sample for obtaining person to be checked according to a conventional method, adds it to the modeling equipped with 500 μ l sample treatment liquids
In expects pipe, be placed at room temperature for take out after ten minutes 120 μ L drops in detection card sample pad on, after 15 minutes under uv analyzer
(model WD-9403A, Liuyi Instruments Plant, Beijing's production, burst of ultraviolel wavelength 365nm) observation testing result.If urine sample
In contain Ureaplasma urealyticum antigen, then with the quantum dot-labeled antibody A bMB3Linear in bonding pad ining conjunction with, pass through chromatography work
With elder generation in conjunction with the anti-MB protein polyclone antibody on nitrocellulose filter after will form at detection line under ultraviolet light excitation
A macroscopic fluorescence detection line, the quantum dot-labeled antibody being not associated with continue chromatography in conjunction with goat anti-rabbit igg after
Macroscopic Article 2 fluorescence nature controlling line is formed under ultraviolet light excitation;If only going out in urine sample to be checked without related antigen
An existing fluorescence nature controlling line.If fluorescence nature controlling line does not occur, detection card failure.
8. the application effect of the immune chromatography reagent kit based on quantum dot-labeled technology is illustrated
The application method of the signified immune chromatography reagent kit based on quantum dot-labeled technology is referring to step 7 in the present embodiment
The operating procedure.
1) specific test
With pathogenic pathogen such as people's mycoplasma pneumoniae (ATCC15531), legionella pneumophilia (ATCC 33152), people III
Type parainfluenza virus viral (ATCC VR-93), stream of people's haemophilus influenza (ATCC 53781), chlamydia pneumoniae (AR-39 plants,
ATCC number 53592), 3 type of adenovirus hominis (GB plants, ATCC number VR-3), 7 type of adenovirus hominis (Gomen plants, ATCC number VR-
7), influenza virus A hominis (H1N1, ATCC number VR-1743), people's influenza B virus (ATCC number VR-790), people's breathing
Road syncytial virus (ATCC number VR26), streptococcus pneumonia (ATCC number 700670) etc. are detected instead of Ureaplasma urealyticum,
Phosphate buffer dilution of the kit detection containing these microorganisms is all negative.
2) clinical trial example
Using Ureaplasma urealyticum detection " goldstandard "-cultivation as reference, the urine of 100 urological department urinary tract infection persons is taken
Kit described in sample step 6 is detected, and cultivation positive rate is 26% (26/100), this kit is 25% (25/
100), the coincidence rate of 2 kinds of methods is % (95/100).Concrete outcome is as shown in table 1.
The testing result of 1 clinical samples of table
The preparation and application of immune chromatography reagent kit of the embodiment 3 based on colloidal gold-labeled method
1. colloidal gold labeled monoclonal antibody AbMB3Linear
A.30nm the preparation of colloidal gold
The 250ml triangular flask that a silication is good is taken, 99ml ultrapure water is added, it is added in 1ml 1% (m/v) HAuCl4 solution
Middle mixing, oil bath heating are simultaneously stirred to boiling.Rapidly join 2ml 1% (m/v) trisodium citrate aqueous solution thereto, solution after
Continuous boiling 10min (solution is changed into red by blue during this).Stop heating, allow solution cooled to room temperature, so
Ultrapure water polishing is added thereto afterwards to 100ml.
B. colloidal gold labeled monoclonal antibody AbMB3Linear
1) the 50ml triangular flask that a silication is good is taken, colloidal gold liquid prepared by 10ml step a is added, is added into golden liquid
240ul 0.2mol/L K2CO3Adjust pH to 8.5;
2) under magnetic stirrer, antibody A bMB3Linear is added in colloidal gold solution, until antibody is final concentration of
10ug/ml should be added dropwise when antibody is added, and continue to stir 45min~60min after adding;
3) reaction completes that 5% (m/v) bovine serum albumin(BSA) (BSA) to final concentration of 1% (m/v), stirring 15~30 is added
Minute, 4 DEG C save backup.
4) 50ml centrifuge tube is packed into after taking out the antibody A bMB3Linear marked, 2500g, 4 DEG C are centrifuged 5 minutes, obtain
To lower sediment and supernatant liquor, discard lower sediment, supernatant liquor is transferred to another 50ml centrifuge tube, 12000g, 4 DEG C from
The heart 30 minutes, lower sediment and supernatant liquor are obtained, supernatant liquor is discarded, lower sediment 10ml colloidal gold buffer is resuspended
Precipitating, then 12000g again, 4 DEG C are centrifuged 30 minutes, obtain lower sediment and supernatant liquor again, lower sediment is finally used
3ml colloidal gold buffer is resuspended, and 4 DEG C save backup, and obtain the solution containing colloidal gold labeled monoclonal antibody AbMB3Linear;
Each component content is respectively in above-mentioned colloidal gold buffer: 10mM Tris, 1% (m/v) BSA, 1% (v/v)
Tween-20,5% (m/v) sucrose and 3 ‰ (m/v) polyvinylpyrrolidone PVP-10, the pH of the colloidal gold buffer are
10.5。
2. the preparation of bonding pad
Polyester fiber film is immersed into 1h in the obtained solution containing colloidal gold labeled monoclonal antibody AbMB3Linear of step 1,
It takes out, is cut into after 25 DEG C of drying after rear specification is 4cm × 0.6cm/ item, 4 DEG C are sealed spare, so far obtained bonding pad.
3. the preparation of sample pad
It takes glass fibre element film one to open, it is impregnated at least 2h in sample pad treatment fluid, then be placed in Biohazard Safety Equipment
After 37 DEG C of aeration-dryings, specification is cut into obtain sample pad, 25 DEG C are sealed after 4cm × 2.5cm/ item.
4. the preparation of detection layers
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone antibody that embodiment 2 is prepared
Being adjusted with phosphate buffer to final concentration with goat anti-rabbit igg is respectively 2.0mg/mL and 1.0mg/mL;The rabbit-anti that will have been diluted
Recombination P1-His fusion protein polyclonal antibody IgG is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitre
On acid cellulose film, detection line is formed;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, 1.0 μ l/cm are set
Amount be sprayed on nitrocellulose filter as nature controlling line, nature controlling line and detection line spacing are 0.7cm;The nitrocellulose that will have been sprayed
37 DEG C of film dry 2h, are cut into the specification of 4cm × 4cm, and 4 DEG C of hermetically dryings save;So far detection layers are made.
5. detecting the assembling of card
Bottom plate is cut into 4cm × 6cm size, it is spare.
Absorbent filter is cut into 4cm × 2.5cm size, it is spare as water absorption pad.
Assembly working first takes the adhered protection film on bottom plate off in operating in Biohazard Safety Equipment, will be described in step 4
Detection layers have nature controlling line and the nitrocellulose filter of detection line pastes on bottom plate, and carefully smooth out film surface.Secondly, by thing
The water absorption pad first cut out is assembled on bottom plate, and having its left side and detection layers right end, 0.2cm's is overlapping, right hand edge then with bottom
The right hand edge alignment of plate is glued and is carefully smoothed out.Bonding pad described in step 2 is overlapped in the left side of detection layers 3 by 0.2cm again
At edge, 0.4cm is sticked on bottom plate.Sample pad described in step 3 is finally then overlapped in by one side 0.2cm to the left edge of bonding pad
Place, another side is aligned with the left edge of bottom plate, sticks on bottom plate and carefully smoothes out.Assembled detection plate is cut out under cutting machine
At the detection card of 4.0mm wide, 4 DEG C of hermetically dryings are kept in dark place.
6. the composition of the immune chromatography reagent kit based on colloidal gold-labeled method
Based on the immune chromatography reagent kit of colloidal gold-labeled method detection card as described in step 5 and sample treatment liquid institute group
At.
7. the application method of the immune chromatography reagent kit based on colloidal gold-labeled method
The 500 μ l of urine specimen for obtaining person to be checked according to a conventional method, adds it to the modeling equipped with 500 μ l sample treatment liquids
In expects pipe, after 50 DEG C of water-bath 20min, rear 120 μ L drops of taking out visually observe after 15 minutes in the sample pad of detection card and detect knot
Fruit.If containing Ureaplasma urealyticum antigen in urine specimen, tied with the antibody A bMB3Linear of the colloid gold label in bonding pad
It closes, will form at detection line after acting on elder generation in conjunction with the anti-MB protein polyclone antibody on nitrocellulose filter by chromatography
Macroscopic one red detection line, the colloidal gold labeled monoclonal antibody being not associated with continue chromatography rear shape in conjunction with goat anti-rabbit igg
At macroscopic Article 2 red nature controlling line;If only there is a red Quality Control without related antigen in urine specimen to be checked
Line.If red nature controlling line does not occur, detection card failure.
8. the application effect of the immune chromatography reagent kit based on colloidal gold-labeled method is illustrated
The application method of the signified immune chromatography reagent kit based on colloidal gold-labeled method is referring to step 7 in the present embodiment
The operating procedure.
1) specific test
With common causative such as legionella pneumophilia (ATCC 33152), I type human parainfluenza viruses (ATCC VR-94), II type
Human parainfluenza viruses (ATCC VR-92), type III human parainfluenza viruses' virus (ATCC VR-93), stream of people's haemophilus influenza
(ATCC 53781), chlamydia pneumoniae (AR-39 plants, ATCC number 53592), 3 type of adenovirus hominis (GB plants, ATCC number VR-
3), 7 type of adenovirus hominis (Gomen plants, ATCC number VR-7), influenza virus A hominis (H1N1, ATCC number VR-1743), people
(ATCC is compiled for influenza B virus (ATCC number VR-790), human respiratory syncytial virus (ATCC number VR26), streptococcus pneumonia
Etc. number 700670) detected instead of Ureaplasma urealyticum, kit detects the phosphate buffer dilution containing these microorganisms
It is all feminine gender.
2) clinical trial example
Using Ureaplasma urealyticum detection " goldstandard "-cultivation as reference, the urine of 100 urological department urinary tract infection persons is taken
Kit described in sample step 6 is detected, and cultivation positive rate is 26% (26/100), this kit is 24% (24/
100), the coincidence rate of 2 kinds of methods is 96% (96/100).Concrete outcome is as shown in table 1.
The testing result of 1 clinical samples of table
It should be pointed out that the foregoing is merely illustrative of the preferred embodiments of the present invention, it is not intended to limit the invention, it is all
Any modification, equivalent replacement for being made within spirit of that invention and principle etc. should be included in protection scope of the present invention it
It is interior.
Claims (1)
1. one kind is formed by immune chromatography reagent kit based on anti-3 type Ureaplasma urealyticum MB protein antibodies, it is characterised in that: described
Kit is the immune chromatography reagent kit based on quantum dot-labeled technology or the immunochromatography reagent based on colloidal gold-labeled method
Box;
Anti- 3 type Ureaplasma urealyticum MB protein antibodies are AbMB3Linearar, and the preparation method of AbMB3Linearar is:
1) after structure biology analysis and Related Experimental Study, 14 of selected 3 type Ureaplasma urealyticum MB protein 10 5-118
Linear epitope of the amino acid as preparation 3 type Ureaplasma urealyticum MB protein antibodies of rabbit-anti, this section of amino acid sequence are
This sequence designations is MB3Linear by KLPREPKPNEQLTI;
2) it after the C-terminal of amino acid sequence MB3Linear described in step 1) being added a cysteine, is automatically synthesized with polypeptide
Instrument synthesis polypeptide simultaneously purifies, polypeptide and carrier protein KLH after purification, forms MB3Linear-KLH compound protein;
3) compound protein synthesized by step 2) is emulsified, in rabbit subcutaneous abdomen multi-point injection after emulsification, is successively injected three times, often
Minor tick 7-10 days;
4) after third time injection 10-12 days, collection isolated contains 3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti
Serum, ELISA detect serum in 3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti potency, the potency of the antibody
In 1:60000 or more;
5) step 2) is synthesized and the polypeptide purified and the Sepharose4B of cyanogen bromide-activated is coupled, form polypeptide affinity chromatography
Column;
6) serum containing 3 type Ureaplasma urealyticum MB albumen single-epitope antibody of rabbit-anti that step 4) obtains is added to step 5) system
In standby affinity column, and after 4 DEG C are incubated overnight, antibody elution obtains 3 type Ureaplasma urealyticum MB albumen list epitope of rabbit-anti
Antibody;Identify that the antibody of this purifying 97% or more, is named as AbMB3Linear by its purity through SDS-PAGE;
When the kit is the immune chromatography reagent kit based on quantum dot-labeled technology, the preparation method of the kit is:
1) quantum dot-labeled antibody A bMB3Linearar:
0.4nmol carboxyl water-soluble quantum dot and 800nmol carbodiimide EDC are sequentially added into microcentrifugal tube, it is slow with MES
Fliud flushing constant volume is 1ml, and mixed solution after 37 DEG C of reaction 5min, adds the antibody of 0.34mg being prepared
AbMB3Linearar is protected from light 2h, and single-ended amino-polyethyleneglycols PEG2000-NH2 to final concentration of 1%m/v is added, closing
Unreacted activated carboxyl site, continues to be protected from light 1h;Sample after reaction is centrifuged with super filter tube, and 6500g is centrifuged 5min, until
Sample after ultrafiltration is transferred in common EP pipe by volume 200ul, and centrifugation obtains upper clear supernate and lower part precipitating except reuniting,
3min is centrifuged under the conditions of 10000g;Upper clear supernate is added on splitter Superdex-200 and is purified, is flowed naturally to upper clear supernate
Enter in cylinder, then rinsed with PBS, the position of sample is observed with ultraviolet light cylinder, when sample starts to flow out from lower part
Start to collect, stops collecting after collecting 1ml;By sample after purification with super filter tube to be shifted after 6500g centrifugal concentrating to 200ul
Interior centrifugation is managed except reuniting to common EP, and the condition being centrifuged to common EP pipe is 10000g, 3min;With phosphoric acid after acquisition supernatant
Salt saves liquid and dilutes 200 times, and 4 DEG C save backup;So far the solution containing quantum dot labelled antibody AbMB3Linearar is made;
Each component content is respectively in the MES buffer: 10.66g/L MES and 0.74g/L EDTA, the MES buffering
The pH7.4 of liquid;
The preparation method that the phosphate saves liquid is to weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate, 0.2g chlorine
Change sodium, 1g bovine serum albumin(BSA) BSA and 0.1gNaN3, it is dissolved in the deionized water of 90ml, extremely with 1mol/L NaOH tune pH
100ml is settled to deionized water after 7.3;
2) bonding pad is prepared
Polyester fiber film is immersed into 1h in the obtained solution containing quantum dot labelled antibody AbMB3Linearar of step 1),
It takes out, is cut into after 25 DEG C of drying after rear specification is 4cm × 0.6cm/ item, 4 DEG C are sealed spare, so far obtained bonding pad;
3) sample pad is prepared
It takes glass fibre element film one to open, glass fibre element film is impregnated at least 3h in sample pad treatment fluid, then be placed in biological peace
In full cabinet after 37 DEG C of aeration-dryings, specification is cut into obtain sample pad, 25 DEG C are sealed after 4cm × 2.5cm/ item;
The preparation method of the sample pad treatment fluid is to weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate, 0.2g chlorine
Change sodium, 2g bovine serum albumin(BSA) BSA, 1ml Tween-20,2g sucrose and 0.5g polyvinylpyrrolidone PVP-10, is dissolved in
In the deionized water of 90ml, 100ml is settled to deionized water with after 1mol/L NaOH tune pH to 7.3;
4) detection layers are prepared
4.1) preparation of anti-MB protein polyclone antibody:
4.1.1) the clone of related gene
Bioinformatic analysis is carried out to 3 type Ureaplasma urealyticum MB albumen, obtains the 3 extracellular guarantors of type Ureaplasma urealyticum MB albumen n end
The peptide fragment the most abundant of epitope in structural domain is kept, finds the corresponding DNA encoding sequence of the peptide fragment, while in this DNA encoding
Chemical synthesis is complete respectively after 5 ' end introducing restriction enzyme site NdeI, 3 ' the end introducing termination signal TAA and restriction enzyme site XhoI of sequence
Gene order is denoted as MB3;The 30- that the protein sequence of MB3 gene coding is natural 3 type Ureaplasma urealyticum memebrane protein MB
150aa;By normal after carrier pUC57 containing this section of artificial synthesized DNA fragmentation is carried out double digestion with NdeI and XhoI respectively
Target fragment is separately recovered in rule method, spare;Double digestion is carried out to carrier pET-28a (+) using NdeI and XhoI simultaneously, and is pressed
The MB3 gene obtained after double digestion is connected into pET-28a (+) carrier by conventional method respectively, and converts Escherichia coli
TOP10 constructs pET-MB3 expression vector;Confirm that expression vector establishment is errorless through digestion and sequencing;Carrier expression recombination
MB3-His fusion protein;
4.1.2 the expression and purification of MB3-His fusion protein) is recombinated
Plasmid will be extracted after identifying correct positive colony bacterium culture, routinely technology is transferred to competence E.coli BL21 (DE3)
In, bacterium solution is coated on the LB plate containing 50 μ g/mL kanamycins after the completion of conversion, according to a conventional method screening expression bacterial strain;
The single bacterium colony with exogenous protein expression ability and inoculation that picking pET-MB3 is converted enter in 100mL LB culture medium, in 37
DEG C overnight incubation;After taking out bacterium solution, 100mL is inoculated in by 1:100 and is contained in the LB culture medium of 50 μ g/mL kanamycins, in 37
DEG C culture is to OD600When=0.6,1mol/L IPTG to final concentration of 1mmol/L is added, bacterium culture, induced fusion are shaken in 37 DEG C
Protein expression;10min collection thallus is centrifuged under 8000r/min after inducing 4h;This thallus is washed with 20mL phosphate buffer
It washs 3 times and carries out ultrasonication, operating condition after being resuspended with 10mL sample-loading buffer are as follows: 50HZ, 200W, ultrasonic 3S, interval 5S,
Work 100 times;After the completion of ultrasound, 12000g centrifugation 15min carries out electrophoresis detection after collecting precipitating and supernatant respectively;It was found that recombination
Albumen MB3-His is present in thallus in a manner of soluble;
Each component content is respectively in the sample-loading buffer: 20mM Na3PO4, 0.5M NaCl and 30mM imidazoles;On described
The pH7.4 of sample buffer;
The purification step for recombinating MB3-His fusion protein is as follows:
His Trap affinity is used after the ultrasonication supernatant of above-mentioned acquisition is filtered with 0.45 μm of filter membrane
Columns is purified with same method to specifications;The specific method is as follows:
A) it is filled distilled water with 5mL syringe, unscrews the plug of column, connected column with syringe with the connector of offer, with
1mL/min flow velocity washes column;
B) it is balanced with 10mL sample-loading buffer, 1mL/min flow velocity;
C) by fusion protein loading, 1mL/min flow velocity;
D) 10mL sample-loading buffer is used, column is washed with 1mL/min flow velocity;
E) 10mL elution buffer is used, with the elution of 1mL/min flow velocity, is in charge of collection, every pipe 1ml, 12%SDS-PAGE detection are closed
And contain the sample of destination protein in elution fraction;After bradford kit carries out determination of protein concentration, concentration is adjusted
For 0.2mg/mL;
Each component content is respectively in the elution buffer: 20mM Na3PO4, 0.5M NaCl and 300mM imidazoles is described to wash
The pH7.4 of de- buffer;
4.1.3) the preparation of anti-MB protein polyclone antibody
Hero is immunized after mixing emulsification according to 200 μ g and 1mL Freund's complete adjuvant with the recombination MB3-His fusion protein of above-mentioned purifying
Property new zealand white rabbit, in dorsal sc multi-point injection, be spaced after 7d be immunized again it is primary, with the weight of above-mentioned purifying after 14d
Group P1-His fusion protein carries out booster immunization, booster immunization 7d after mixing emulsification according to 200 μ g and 1mL incomplete Freund's adjuvant
Booster immunization is primary again in same way as described above again afterwards;Haemanalysis antibody titer is taken after 7d;Until antibody titer indirect ELISA
Method measures antibody titer and is greater than 1 × 105Culling heart blood afterwards separates serum, with Protein G affinity column, in strict accordance with behaviour
Book purified polyclonal antibodies IgG is explained, measure antibody concentration with triumphant base Braford protein content detection kit and uses phosphoric acid
Salt buffer is adjusted to 1mg/mL, and -20 DEG C of preservations are spare, and anti-MB protein polyclone antibody is so far made;
4.2) detection layers are prepared
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone antibody that step 4.1) is prepared and sheep
It is respectively 2.0mg/mL and 1.0mg/mL that anti-rabbit IgG, which is adjusted with phosphate buffer to final concentration,;The anti-MB albumen that will have been diluted
Polyclonal antibody is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter, forms detection
Line;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter
As nature controlling line, nature controlling line and detection line spacing are 0.7cm;37 DEG C of the nitrocellulose filter dry 2h that will have been sprayed, are cut into 4cm
The specification of × 4cm, 4 DEG C of hermetically dryings save;So far detection layers are made;
The preparation method of the phosphate buffer is: weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate and
0.2g sodium chloride, is dissolved in the deionized water of 90ml, is settled to after 1mol/L NaOH tune pH to 7.3 with deionized water
100ml;
5) assembling detection card
5.1) bottom plate is cut into 4cm × 7.3cm size, it is spare;
5.2) absorbent filter is cut into 4cm × 3cm size, it is spare as water absorption pad;
5.3) adhered protection film on bottom plate that step 5.1) is prepared is taken off, detection layers described in step 4) is had
Nature controlling line and the nitrocellulose filter of detection line paste on bottom plate, and smooth out film surface;
5.4) the ready water absorption pad of step 5.2) is assembled on bottom plate, there is the left side of water absorption pad with the right end of detection layers
The overlapping of 0.2cm, the right hand edge of water absorption pad are then aligned with the right hand edge of bottom plate and glue and smooth out;Again by combination described in step 2)
Pad is overlapped at the left edge of detection layers by 0.3cm, and 0.3cm is sticked on bottom plate;
5.5) sample pad described in step 3) is then overlapped at the left edge of bonding pad by one side 0.3cm, another side and bottom plate
Left edge alignment, stick on bottom plate and smooth out;Assembled detection plate is cut into the detection card of 4.0mm wide under cutting machine, 4
DEG C hermetically drying is kept in dark place;
When the kit is the immune chromatography reagent kit based on colloidal gold-labeled method, the preparation method of the kit is:
1) colloidal gold labeled monoclonal antibody AbMB3Linearar:
1.1) 30nm colloidal gold solution is prepared:
99ml ultrapure water is added, by 1ml1%m/v HAuCl in the 250ml triangular flask for taking a silication good4250ml tri- is added in solution
It is mixed in the bottle of angle and with ultrapure water, oil bath heating is simultaneously stirred to boiling;2ml1%m/v lemon is rapidly joined into 250ml triangular flask
Lemon three sodium water solutions of acid, solution continue the 10min that boils, the stopping when solution in 250ml triangular flask is changed into red by blue
Then ultrapure water polishing is added extremely into 250ml triangular flask in solution cooled to room temperature in 250ml triangular flask by heating
100ml;
1.2) colloidal gold labeled monoclonal antibody AbMB3Linear:
1.2.1 colloidal gold solution prepared by 10ml step 1.1) is added, to colloid in the 50ml triangular flask for) taking a silication good
240ul0.2mol/L K is added in golden liquid2CO3Adjust pH to 8.5;
1.2.2) under magnetic stirrer, antibody A bMB3Linear is added in colloidal gold solution, until antibody is final concentration of
10ug/ml is added dropwise when antibody is added, and continues to stir 45min~60min after adding;
1.2.3) reaction completion addition 5%m/v bovine serum albumin(BSA) BSA to final concentration of 1%m/v, stirring 15~30 minutes, 4
It DEG C saves backup;
1.2.4 50ml centrifuge tube is packed into after) taking out the antibody A bMB3Linear marked, 2500g, 4 DEG C are centrifuged 5 minutes, obtain
To lower sediment and supernatant liquor, discard lower sediment, supernatant liquor is transferred to another 50ml centrifuge tube, 12000g, 4 DEG C from
The heart 30 minutes, lower sediment and supernatant liquor are obtained, supernatant liquor is discarded, lower sediment 10ml colloidal gold buffer is resuspended
Precipitating, then 12000g again, 4 DEG C are centrifuged 30 minutes, obtain lower sediment and supernatant liquor again, lower sediment is finally used
3ml colloidal gold buffer is resuspended, and 4 DEG C save backup, and obtain the solution containing colloidal gold labeled monoclonal antibody AbMB3Linear;
Each component content is respectively in the colloidal gold buffer: 10mM Tris, 1%m/vBSA, 1%v/v Tween-20,
5%m/v sucrose and 3 ‰ m/v polyvinylpyrrolidone PVP-10, the pH of the colloidal gold buffer are 10.5;
2) bonding pad is prepared
Polyester fiber film is immersed into 1h in the obtained solution containing colloidal gold labeled monoclonal antibody AbMB3Linear of step 1), is taken
Out, be cut into after 25 DEG C of dryings rear specification be 4cm × 0.6cm/ item after, 4 DEG C be sealed it is spare, so far be made bonding pad;
3) sample pad is prepared
It takes glass fibre element film one to open, glass fibre element film is impregnated at least 2h in sample pad treatment fluid, then be placed in biological peace
In full cabinet after 37 DEG C of aeration-dryings, specification is cut into obtain sample pad, 25 DEG C are sealed after 4cm × 1.5cm/ item;
The preparation method of the sample pad treatment fluid be weigh 0.242g Tris, 1g bovine serum albumin(BSA) BSA, 1ml Tween-20,
5g sucrose and 0.3g polyvinylpyrrolidone PVP-10, are dissolved in the deionized water of 90ml, extremely with 1mol/L NaOH tune pH
100ml is settled to deionized water after 11;
4) detection layers are prepared
4.1) preparation of anti-MB protein polyclone antibody:
4.1.1) the clone of related gene
Bioinformatic analysis is carried out to 3 type Ureaplasma urealyticum MB albumen, obtains the 3 extracellular guarantors of type Ureaplasma urealyticum MB albumen n end
The peptide fragment the most abundant of epitope in structural domain is kept, finds the corresponding DNA encoding sequence of the peptide fragment, while in this DNA encoding
Chemical synthesis is complete respectively after 5 ' end introducing restriction enzyme site NdeI, 3 ' the end introducing termination signal TAA and restriction enzyme site XhoI of sequence
Gene order is denoted as MB3;The 30- that the protein sequence of MB3 gene coding is natural 3 type Ureaplasma urealyticum memebrane protein MB
150aa;Its protein complete sequence is as shown in sequence table;Carrier pUC57 containing this section of artificial synthesized DNA fragmentation is used respectively
Target fragment is separately recovered after carrying out double digestion in NdeI and XhoI according to a conventional method, spare;Simultaneously using NdeI and XhoI to load
Body pET-28a (+) carries out double digestion, and the MB3 gene obtained after double digestion is connected into pET-28a respectively according to a conventional method
In (+) carrier, and Escherichia coli TOP10 is converted, constructs pET-MB3 expression vector;Confirm that expression carries through digestion and sequencing
Body building is errorless;Carrier expression recombination MB3-His fusion protein;
4.1.2 the expression and purification of MB3-His fusion protein) is recombinated
Plasmid will be extracted after identifying correct positive colony bacterium culture, routinely technology is transferred to competence E.coli BL21 (DE3)
In, bacterium solution is coated on the LB plate containing 50 μ g/mL kanamycins after the completion of conversion, according to a conventional method screening expression bacterial strain;
The single bacterium colony with exogenous protein expression ability and inoculation that picking pET-MB3 is converted enter in 100mL LB culture medium, in 37
DEG C overnight incubation;After taking out bacterium solution, 100mL is inoculated in by 1:100 and is contained in the LB culture medium of 50 μ g/mL kanamycins, in 37
DEG C culture is to OD600When=0.6,1mol/L IPTG to final concentration of 1mmol/L is added, bacterium culture, induced fusion are shaken in 37 DEG C
Protein expression;10min collection thallus is centrifuged under 8000r/min after inducing 4h;This thallus is washed with 20mL phosphate buffer
It washs 3 times and carries out ultrasonication, operating condition after being resuspended with 10mL sample-loading buffer are as follows: 50HZ, 200W, ultrasonic 3S, interval 5S,
Work 100 times;After the completion of ultrasound, 12000g centrifugation 15min carries out electrophoresis detection after collecting precipitating and supernatant respectively;It was found that recombination
Albumen MB3-His is present in thallus in a manner of soluble;
Each component content is respectively in the sample-loading buffer: 20mM Na3PO4, 0.5M NaCl and 30mM imidazoles;On described
The pH7.4 of sample buffer;
The purification step for recombinating MB3-His fusion protein is as follows:
His Trap affinity is used after the ultrasonication supernatant of above-mentioned acquisition is filtered with 0.45 μm of filter membrane
Columns is purified with same method to specifications;The specific method is as follows:
A) it is filled distilled water with 5mL syringe, unscrews the plug of column, connected column with syringe with the connector of offer, with
1mL/min flow velocity washes column;
B) it is balanced with 10mL sample-loading buffer, 1mL/min flow velocity;
C) by fusion protein loading, 1mL/min flow velocity;
D) 10mL sample-loading buffer is used, column is washed with 1mL/min flow velocity;
E) 10mL elution buffer is used, with the elution of 1mL/min flow velocity, is in charge of collection, every pipe 1ml, 12%SDS-PAGE detection are closed
And contain the sample of destination protein in elution fraction;After bradford kit carries out determination of protein concentration, concentration is adjusted
For 0.2mg/mL;
Each component content is respectively in the elution buffer: 20mM Na3PO4, 0.5M NaCl and 300mM imidazoles is described to wash
The pH7.4 of de- buffer;
4.1.3) the preparation of anti-MB protein polyclone antibody
Hero is immunized after mixing emulsification according to 200 μ g and 1mL Freund's complete adjuvant with the recombination MB3-His fusion protein of above-mentioned purifying
Property new zealand white rabbit, in dorsal sc multi-point injection, be spaced after 7d be immunized again it is primary, with the weight of above-mentioned purifying after 14d
Group P1-His fusion protein carries out booster immunization, booster immunization 7d after mixing emulsification according to 200 μ g and 1mL incomplete Freund's adjuvant
Booster immunization is primary again in same way as described above again afterwards;Haemanalysis antibody titer is taken after 7d;Until antibody titer indirect ELISA
Method measures antibody titer and is greater than 1 × 105Culling heart blood afterwards separates serum, with Protein G affinity column, in strict accordance with behaviour
Book purified polyclonal antibodies IgG is explained, measure antibody concentration with triumphant base Braford protein content detection kit and uses phosphoric acid
Salt buffer is adjusted to 1mg/mL, and -20 DEG C of preservations are spare, and anti-MB protein polyclone antibody is so far made;
4.2) detection layers are prepared
Nitrocellulose filter is cut into 4cm × 4cm size;The anti-MB protein polyclone antibody that step 4.1) is prepared and sheep
It is respectively 2.0mg/mL and 1.0mg/mL that anti-rabbit IgG, which is adjusted with phosphate buffer to final concentration,;The anti-MB albumen that will have been diluted
Polyclonal antibody is fitted into BIODOT and draws in film instrument spray head, and the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter, forms detection
Line;The anti-rabbit IgG diluted is fitted into BIODOT to draw in film instrument spray head, the amount of 1.0 μ l/cm of setting is sprayed on nitrocellulose filter
As nature controlling line, nature controlling line and detection line spacing are 0.7cm;37 DEG C of the nitrocellulose filter dry 2h that will have been sprayed, are cut into 4cm
The specification of × 4cm, 4 DEG C of hermetically dryings save;So far detection layers are made;
The preparation method of the phosphate buffer is: weigh 0.29g disodium hydrogen phosphate, 0.0295g sodium dihydrogen phosphate and
0.2g sodium chloride, is dissolved in the deionized water of 90ml, is settled to after 1mol/L NaOH tune pH to 7.3 with deionized water
100ml;
5) assembling detection card
5.1) bottom plate is cut into 4cm × 6cm size, it is spare;
5.2) absorbent filter is cut into 4cm × 2.5cm size, it is spare as water absorption pad;
5.3) adhered protection film on bottom plate that step 5.1) is prepared is taken off, detection layers described in step 4) is had
Nature controlling line and the nitrocellulose filter of detection line paste on bottom plate, and smooth out film surface;
5.4) the ready water absorption pad of step 5.2) is assembled on bottom plate, there is the left side of water absorption pad with the right end of detection layers
The overlapping of 0.2cm, the right hand edge of water absorption pad are then aligned with the right hand edge of bottom plate and glue and smooth out;Again by combination described in step 2)
Pad is overlapped at the left edge of detection layers by 0.2cm, and 0.4cm is sticked on bottom plate;
5.5) sample pad described in step 3) is then overlapped at the left edge of bonding pad by one side 0.2cm, another side and bottom plate
Left edge alignment, stick on bottom plate and smooth out;Assembled detection plate is cut into the detection card of 4.0mm wide under cutting machine, 4
DEG C hermetically drying is kept in dark place.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610318423.7A CN105968197B (en) | 2016-05-13 | 2016-05-13 | A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610318423.7A CN105968197B (en) | 2016-05-13 | 2016-05-13 | A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105968197A CN105968197A (en) | 2016-09-28 |
CN105968197B true CN105968197B (en) | 2019-08-16 |
Family
ID=56992563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610318423.7A Active CN105968197B (en) | 2016-05-13 | 2016-05-13 | A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105968197B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108333368A (en) * | 2018-02-07 | 2018-07-27 | 深圳市伯劳特生物制品有限公司 | The kit and preparation method of calprotectin in a kind of detection human faecal mass |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1726394A (en) * | 2002-10-15 | 2006-01-25 | 阿伯麦特里科斯公司 | Sets of digital antibodies directed against short epitopes, and methods using same |
CN101655496A (en) * | 2009-09-10 | 2010-02-24 | 杭州艾力康医药科技有限公司 | Test strip for quickly detecting ureaplasma urealyticum antibodies in saliva |
CN103889448A (en) * | 2011-04-29 | 2014-06-25 | 贝勒医学院 | Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection |
CN203772870U (en) * | 2013-10-15 | 2014-08-13 | 李克生 | Gold standard rapid detection kit for detecting antigens of ureaplasma urealyticum (UU) |
CN104198703A (en) * | 2014-08-18 | 2014-12-10 | 湖北工业大学 | Human mycoplasma pneumoniae gold-marked silver-stained immunochromatographic assay kit and preparation method and application thereof |
CN105277693A (en) * | 2014-08-18 | 2016-01-27 | 董俊 | Human parainfluenza virus quantum dot immunochromatography typing detection card, preparation method and applications |
-
2016
- 2016-05-13 CN CN201610318423.7A patent/CN105968197B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1726394A (en) * | 2002-10-15 | 2006-01-25 | 阿伯麦特里科斯公司 | Sets of digital antibodies directed against short epitopes, and methods using same |
CN101655496A (en) * | 2009-09-10 | 2010-02-24 | 杭州艾力康医药科技有限公司 | Test strip for quickly detecting ureaplasma urealyticum antibodies in saliva |
CN103889448A (en) * | 2011-04-29 | 2014-06-25 | 贝勒医学院 | Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection |
CN203772870U (en) * | 2013-10-15 | 2014-08-13 | 李克生 | Gold standard rapid detection kit for detecting antigens of ureaplasma urealyticum (UU) |
CN104198703A (en) * | 2014-08-18 | 2014-12-10 | 湖北工业大学 | Human mycoplasma pneumoniae gold-marked silver-stained immunochromatographic assay kit and preparation method and application thereof |
CN105277693A (en) * | 2014-08-18 | 2016-01-27 | 董俊 | Human parainfluenza virus quantum dot immunochromatography typing detection card, preparation method and applications |
Non-Patent Citations (3)
Title |
---|
Epitope mapping of the variable repetitive region with the MB antigen of Ureaplasma urealyticum;XIAOTIAN ZHENG et al.;《CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY》;19961130;第3卷(第6期);774-778 |
Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation;XIAOTIAN ZHENG et al.;《INFECTION AND IMMUNITY》;19950331;第63卷(第3期);891-898 |
解脲支原体MB抗原保守区的基因克隆、表达及其单克隆抗体的制备;杜庆辉;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20150215;E059-149 |
Also Published As
Publication number | Publication date |
---|---|
CN105968197A (en) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104198703B (en) | People's mycoplasma pneumoniae gold label silver stain immunochromatographytest test kit and its preparation method and application | |
CN102539782B (en) | Immune chromatography test strip for detecting cystic echinococcosis and alveolar echinococcosis | |
WO2022032983A1 (en) | Quantum dot microsphere immunochromatography test strip for detection of african swine fever virus mucous membrane siga antibody, and use thereof | |
CN105675873B (en) | A kind of detection kit and its application | |
CN104316703B (en) | A kind of Mycoplasma bovis test strip and its preparation method | |
CN107407679B (en) | Immunological detection method and kit for mycoplasma pneumoniae | |
CN107573417A (en) | Mycoplasma pneumoniae chimeric antigen, the antigen detecting agent and both preparation methods | |
CN105319359B (en) | Streptococcus pneumoniae quantum dot immunochromatographic assay detection card and preparing method and application thereof | |
CN105753981B (en) | The immune chromatography reagent kit of anti-human Respiratory Syncytial Virus(RSV) N protein antibody and the application antibody | |
CN105277693A (en) | Human parainfluenza virus quantum dot immunochromatography typing detection card, preparation method and applications | |
CN107430124B (en) | Immunological detection method and kit for mycoplasma pneumoniae | |
CN114736290B (en) | Nanometer antibody capable of recognizing porcine pseudorabies virus with high accuracy and sensitivity, preparation method and application | |
CN109970851A (en) | The preparation method of monoclonal antibody of CCV virus M protein and preparation method thereof, immunity colloidal gold test paper strip | |
CN105585633B (en) | The immune chromatography reagent kit of anti-human haemophilus influenzae P6 protein antibodies and the application antibody | |
CN105968197B (en) | A kind of anti-3 type Ureaplasma urealyticum MB protein antibodies and the immune chromatography reagent kit using the antibody | |
CN105585635B (en) | The immune chromatography reagent kit of anti-human mycoplasma pneumoniae p1 protein antibody and the application antibody | |
CN105753982B (en) | The immune chromatography reagent kit of anti-human streptococcus pneumonia fam1 family PspA protein antibodies and the application antibody | |
CN111505289A (en) | Peste des petits ruminants detection kit | |
CN204028084U (en) | People's Chlamydia pneumoniae quantum dot immune chromatography test card | |
CN102608330A (en) | Immunochromatographic strip for detecting alveolar echinococcosis and preparation method thereof | |
CN105801692B (en) | The immune chromatography reagent kit of anti-3 type Ureaplasma urealyticum MB protein antibodies and the application antibody | |
CN105242040B (en) | Human Haemophilus influenza quantum dot immunochromatography detection card, preparation method and application thereof | |
CN105585634B (en) | The immune chromatography reagent kit of anti-human streptococcus pneumonia fam2 family PspA protein antibodies and the application antibody | |
CN101781360B (en) | Recombinant rubella virus protein and application | |
CN105319360B (en) | People's CPN quantum dot immune chromatography detection card and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |